Dermaxime anti-aging skin care cosmetics     

      

 

Home
Products
Ordering
Shipping
About Us
Search
FREE Articles
Formulas
Guarantee
South African Site

Serilesine® - stimulation of keratinocyte creation

Different clinical tests were done to prove that Serilesine helps to keep skin aging at bay by stimulating various mechanisms.

This page looks at how it stimulates the creation of keratinocytes.

To place this in context with how it helps to fight aging and to have a younger looking skin, please look at the Serilesine summary page by clicking here.

stimulation of keratinocyte creation

Serilesine is used in the following products:

In vitro keratinocyte proliferation

Cell proliferation is evaluated by a fluorescence-based cell viability method. Live cells are distinguished by the presence of intracellular esterase activity, determined by the enzymatic conversion of the nonfluorescent cell-permeant calcein-AM to the intensely fluorescent calcein, which is retain within live cells and imparts an intense green fluorescence.

Samples are tested at the following concentrations in Epilife medium without phenol red (Cascade Biologics): 2.5 mg/ml, 0.83 mg/ml, 0.28 mg/ml, 0.093 mg/ml, 0.031 mg/ml. Non treated cells are used as controls.

Human Epidermal Keratinocytes (HEKa, Cascade Biologics) were grown until confluence in Epilife medium (Cascade Biologics) supplemented with specific growth factors for keratinocytes. Human Epidermal Keratinocytes were trypsinised and 1 x104 cells/well were seeded at 96-well plates.

After 24 h incubation at 37ş C in 5% CO2 humidified air, fresh medium was added with scalar dilutions of tested product. Non treated cells (only medium) were used as controls. Cells were incubated for an additional 48 h at 37ş C in 5% CO2 humidified air.

At this time, well medium was replaced with 100 µl of 0.4 µM calcein-AM (Molecular Probes) in Epilife medium without phenol red (Cascade Biologics) following the method described by Lynch et al.

The fluorescence was read at λexc=485 nm and λem=530 nm in a microtiter plate reader (1420 VICTOR2, EG &G Wallace). The proliferation was calculated as: T/C x 100, where T represents the absorbance of test wells and C that of the control wells.

As shown below, the product SERILESINE® has shown a stimulatory effect on keratinocyte cell growth, after 48 hours. Since the control was taken as 100%, the highest dose of the hexapeptide induced an increase in keratinocyte proliferation of 37.6%.

skin firmness

Due to the fact that combining all the images on one page makes it too large to download within a fair period of time, we created different pages dealing with each aspect that was tested.

The other test that were performed can be viewed by clicking the hyperlink.

If you are looking for the summary page of Serilesine please click here.

skin firmness increased

Other cosmetic ingredients

Dermaxime products

Rejuvenating Face Wash

Rejuvenating Face Wash Refill

Rejuvenating Toner

Rejuvenating Toner Refill

Rejuvenating Serum

Rejuvenating Day Cream

Rejuvenating Night Cream

Rejuvenating Neck Cream

Instant Eye Lift Gel

Rejuvenating Eye Cream

Rejuvenating Face Scrub

Rejuvenating Face Mask

Purifying Face Mask

Problem Skin Face Wash

Problem Skin Toner

Problem Skin Moisturizing Day Gel

Problem Skin Night Care Lotion

Spot Treatment Cream

Problem Skin Enzyme Cleanse

Problem Skin Face Mask

Cellumend Cellulite Cream

Moisturizing Body Lotion

Intensive Hand Treatment Balm

Nail and Cuticle Balm

Refining Body Scrub

Refreshing Foot Cream




Statements made on the products, ingredients and general information have not been evaluated by the FDA and should not be seen as health claims. All ingredients used in our products are safe and are in no way banned, controlled or restricted.
All products are manufactured following strict GMP and ISO standards.

home | products | formulations | ordering | shipping | links to other websites
contact us | search | free information | South African Orders

© Copyright Dermaxime (Pty) Ltd 2001 - 2008.

The entire content of this website is copyrighted - including text, photographs, logos, metatags etc., and no part whatsoever may be copied and used - privately, for educational purposes or publishing or for commercial application - without the written permission of Dermaxime (Pty) Ltd.

Our site was last updated on 2 May 2008.